Azathioprine Metabolite Measurements in the Treatment of Autoimmune Hepatitis in Pediatric Patients: A Preliminary Report
Rumbo C, Emerick K, Emre S, Shneider B. Azathioprine Metabolite Measurements in the Treatment of Autoimmune Hepatitis in Pediatric Patients: A Preliminary Report. Journal Of Pediatric Gastroenterology And Nutrition 2002, 35: 391-398. DOI: 10.1002/j.1536-4801.2002.tb07844.x.Peer-Reviewed Original ResearchPediatric patientsAZA metabolite levelsAzathioprine metabolite measurementsMedication-induced toxicityNormal TPMT levelsInflammatory bowel diseaseCohort of childrenThiopurine methyltransferase enzyme activityRoutine biochemical studiesPotential adverse effectsAutoimmune hepatitisAZA doseMedication toxicityTPMT levelsALT levelsSteroid requirementsBowel diseaseDose escalationStandard dosesMetabolite testingMean doseTherapeutic effectBlood samplesAzathioprinePatients